SNP database from 1000G or NHLBI projects are based on general population, or presumably "healthy" people.
A long-time confusing question for me is, ClinSeq SNP project is based on just patients?
I look into their website, and I'm sure that the volunteers involved in the project DEFINITELY include "patients" or at least involving various types of syndromes, and in their genome research paper they also reported some rare missense mutations which they think associated with say, some abnormal cardiovascular phenotypes.
And also you can find, in dbSNP, there'll always be some rare mutations absent from 1000G/NHLBI, but present in ClinSeq.
Then my questions are: Does ClinSeq involve ONLY patients, or also involve general population? And for those rare mutations ONLY found by ClinSeq, can we view them as highly-likely deleterious or pathogenic?
Thanks!
Thanks! So you also think the recruited individuals, to some extent, are "patients"? And mutations ONLY found in Clinseq can be viewed as more likely to be deleterious?
In the broadest sense a patient is any recipient of health care services. In that sense these are all patients. But I think they are not all patients in the sense of being sick or exhibiting any type disorder. As for your followup question I would not venture to state anything since I have not studied the paper in sufficient detail. Most information is listed in the paper in various sections.